Long COVID Trial, Recruiting (NCT05228691)

Long COVID Trial, Recruiting NCT05228691 Sponsor: University of Las Palmas de Gran Canaria Condition: Long COVID

Printed from Voxsanity (voxsanity.com.au) — NCT05228691 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Long Covid

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who tested positive for COVID-19 on or after March 14, 2020 (when Spain declared a state of emergency due to the pandemic).
People who have had ongoing symptoms linked to COVID-19 for at least 12 weeks after their initial diagnosis.
People who have a sufficient level of understanding and physical ability to complete the assessments involved in the trial.

Who may not be able to join:

People who had pre-existing health conditions before getting COVID-19 where the symptoms of those conditions are similar to long COVID symptoms.
People who have been diagnosed with fibromyalgia.
People who have been diagnosed with chronic fatigue.
People who have a neuromuscular disease (a condition affecting the nerves and muscles).
People who have not signed the required consent form agreeing to take part.
People who are currently receiving treatment for active cancer.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Aníbal Báez Suárez, PhD, University of Las Palmas de Gran Canaria

Phone: +34652077692

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05228691

Sponsor: University of Las Palmas de Gran Canaria

Phase: Not Applicable

Status: Recruiting

Condition: Long COVID

Trial contact: +34652077692

More information: https://clinicaltrials.gov/study/NCT05228691

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who tested positive for COVID-19 on or after March 14, 2020 (when Spain declared a state of emergency due to the pandemic).
People who have had ongoing symptoms linked to COVID-19 for at least 12 weeks after their initial diagnosis.
People who have a sufficient level of understanding and physical ability to complete the assessments involved in the trial.

Who may not be able to join:

People who had pre-existing health conditions before getting COVID-19 where the symptoms of those conditions are similar to long COVID symptoms.
People who have been diagnosed with fibromyalgia.
People who have been diagnosed with chronic fatigue.
People who have a neuromuscular disease (a condition affecting the nerves and muscles).
People who have not signed the required consent form agreeing to take part.
People who are currently receiving treatment for active cancer.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Las Palmas de Gran Canaria

Registry

ClinicalTrials.gov

Start date

22 March 2022

Est. completion

22 December 2025

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Post-COVID-19 Functional Status scale; Short Physical Performance Battery; Aerobic capacity; Muscle Strength

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov